Instead, IHC analysis of tumor sections displayed a reduced expression of CD-31 and Ki-67 (Fig. 6J and K) in ifetroban-treated tumor sections, indicating that ifetroban impacts tumor vasculature and proliferation to modulate tumor growth. This evidence concerns the gene MKI67 and neoplasm.